Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dan, Bercovich"'
Autor:
Christie M. Ballantyne, Danièle Zoch, Dan Bercovich, Olaf Bodamer, Arthur L. Beaudet, Michael Schlabach
Publikováno v:
Clinical Chemistry. 48:1913-1918
Background: Autosomal dominant familial hypercholesterolemia (FH) attributable to mutations in the LDL receptor (LDLR) gene is one of the most common genetic disorders associated with significant morbidity and mortality. Definitive diagnosis would he
Autor:
Ninette Amariglio, Andrea Teigler-Schlegel, Andrea Biondi, Inna Muler, Batia Stark, Oskar A. Haas, Dan Bercovich, Jan Trka, Sabine Strehl, Helena Kempski, Shai Izraeli, Liat Rainis, Gideon Rechavi
Publikováno v:
Blood. 102(3)
Patients with Down syndrome (DS) frequently develop 2 kinds of clonal megakaryocytosis: a common, congenital, spontaneously resolving, transient myeloproliferative disorder (TMD) and, less commonly, childhood acute megakaryoblastic leukemia (AMKL). R
Autor:
Olaf A, Bodamer, Dan, Bercovich, Michael, Schlabach, Christie, Ballantyne, Danièle, Zoch, Arthur L, Beaudet
Publikováno v:
Clinical chemistry. 48(11)
Autosomal dominant familial hypercholesterolemia (FH) attributable to mutations in the LDL receptor (LDLR) gene is one of the most common genetic disorders associated with significant morbidity and mortality. Definitive diagnosis would help to initia
Autor:
Marsha Zeigler, Dan Bercovich, Asaad Khoury, Horachio Plotkin, Avraham Lorber, Gad Bar-Joseph, Deeksha Bali, Priya S. Kishnani, Eli Herskovitz, Dan J. Eldad, Dalia Natan, Hanna Mandel
Publikováno v:
Clinical Therapeutics. 33:S17
Autor:
Arndt Borkhardt, Martin Schrappe, Dan Bercovich, Linda M. Scott, Giuseppe Basso, Oskar A. Haas, Martin Stanulla, Smadar Avigad, Ithamar Ganmore, Giovanni Cazzaniga, Shai Izraeli, Owen P. Smith, Jean-Pierre Bourquin, Andrea Biondi, Sabine Strehl, Helena Kempski, Batia Stark, Anthony R. Green, Vera Binder, Gunnar Cario, Jan Trka, Bella Bielorei
Publikováno v:
Blood. 110:LB6-LB6
Additional copies of chromosome (chr) 21 are the most common chromosomal aneuploidy in childhood leukemia. Patients with DS have a markedly increased risk for both AML and ALL. Thus trisomy 21 is leukemogenic. DS-AML is uniquely characterized by an a